Amplexd Therapeutics, Inc.
Amplexd Therapeutics, Inc.
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytologic Abnormalities | Atypical Squamous Cells of Undetermined Significance, Atypical Squamous Cells of the Cervix, DNA Virus Infections, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Infections, Low-Grade Squamous Intraepithelial Lesions, Morphological and Microscopic Findings, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Squamous Intraepithelial Lesions, Tumor Virus Infections, Urogenital Diseases, cervix disorder, dysplasia of cervix, female reproductive system disorder, human papilloma virus infection, infectious disease, neoplasm, precancerous condition, sexually transmitted disease, uterine disorder, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 2 | 2026-05-14 | NCT07572396 |